Stress Reduction in Ovarian Cancer
Status: | Completed |
---|---|
Conditions: | Ovarian Cancer |
Therapuetic Areas: | Oncology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 4/17/2018 |
Start Date: | February 2013 |
End Date: | December 6, 2016 |
Stress Reduction During Primary Adjuvant Chemotherapy for Ovarian Cancer
The purpose of this study is to investigate the effects of a stress reduction program on the
quality of life of ovarian cancer patients during primary adjuvant chemotherapy.
quality of life of ovarian cancer patients during primary adjuvant chemotherapy.
Inclusion Criteria:
- Subjects must have an initial diagnosis of ovarian, fallopian tube or primary
peritoneal cancer who completed primary ovarian cancer surgery or 3 cycles of
neoadjuvant chemotherapy with interval cytoreductive surgery (ICS).
- Final pathology diagnosis of stage I-IV ovarian, fallopian tube or primary peritoneal
cancer with plan to receive primary adjuvant chemotherapy or completion of
chemotherapy after ICS.
- Receive chemotherapy at the University of Wisconsin-Madison.
- Subjects must be at least 18 years of age.
- English-speaking
- Subjects must be able to use audio media, and read and understand the study manual.
- ECOG performance status 0-2.
- Subjects must have a phone.
Exclusion Criteria:
- Subjects participating in a meditation practice more than 1 hour per week prior to
surgery and/or chemotherapy administration.
- Subjects with recurrent ovarian, fallopian tube or primary peritoneal cancer.
- Subjects with diagnosis of Chronic Fatigue Syndrome (CFS).
- Subjects unable to use audio media due to auditory dysfunction.
- Subjects unable to read written English.
- Subjects who are prisoners or incarcerated.
We found this trial at
1
site
750 Highland Avenue
Madison, Wisconsin 53792
Madison, Wisconsin 53792
Principal Investigator: Stephen Rose, MD
Phone: 800-622-8922
Click here to add this to my saved trials